* Inspire Medical Systems Inc INSP.N INSP.K is expected
to show a rise in quarterly revenue when it reports results on
August 1.
* The Golden Valley Minnesota-based company is expected to
report
a 49.2% increase in revenue to $136.344 million from $91.39
million a year ago, according to the mean estimate from 14
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Inspire Medical
Systems
Inc is for a loss of 57 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Inspire
Medical
Systems Inc is $355, above its last closing price of $288.70.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 -0.67 -0.66 -0.53 Beat 19.7
Dec. 31 2023 -0.48 -0.57 0.10 Beat 117.7
Sep. 30 2022 -0.74 -0.77 -0.60 Beat 21.7
Jun. 30 2022 -0.61 -0.62 -0.53 Beat 14.3
Mar. -0.75 -0.80 -0.61 Beat 23.4
31 2022
Dec. 31 2021 -0.41 -0.44 -0.09 Beat 79.4
Sep. 30 2021 -0.60 -0.61 -0.38 Beat 38.2
Jun. 30 2021 -0.63 -0.64 -0.48 Beat 25.1
This summary was machine generated July 29 at 02:02 GMT. All
figures in US dollars unless otherwise stated